152 related articles for article (PubMed ID: 34831413)
21. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
[TBL] [Abstract][Full Text] [Related]
23. The molecular pathogenesis of mycosis fungoides and Sézary syndrome.
Döbbeling U
G Ital Dermatol Venereol; 2008 Dec; 143(6):385-94. PubMed ID: 19169211
[TBL] [Abstract][Full Text] [Related]
24. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
[TBL] [Abstract][Full Text] [Related]
25. Detection of TCR-gamma gene rearrangements in early mycosis fungoides by non-radioactive PCR-SSCP.
Murphy M; Signoretti S; Kadin ME; Loda M
J Cutan Pathol; 2000 May; 27(5):228-34. PubMed ID: 10847547
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides in Taiwan shows a relatively high frequency of large cell transformation and CD56 expression.
Wang RC; Sakata S; Chen BJ; Chang ST; Hsieh PP; Yang CS; Baba S; Takeuchi K; Chuang SS
Pathology; 2018 Dec; 50(7):718-724. PubMed ID: 30348505
[TBL] [Abstract][Full Text] [Related]
27. miR-155 is involved in tumor progression of mycosis fungoides.
Moyal L; Barzilai A; Gorovitz B; Hirshberg A; Amariglio N; Jacob-Hirsch J; Maron L; Feinmesser M; Hodak E
Exp Dermatol; 2013 Jun; 22(6):431-3. PubMed ID: 23711069
[TBL] [Abstract][Full Text] [Related]
28. CADM1 is a diagnostic marker in early-stage mycosis fungoides: Multicenter study of 58 cases.
Yuki A; Shinkuma S; Hayashi R; Fujikawa H; Kato T; Homma E; Hamade Y; Onodera O; Matsuoka M; Shimizu H; Iwata H; Abe R
J Am Acad Dermatol; 2018 Dec; 79(6):1039-1046. PubMed ID: 29928911
[TBL] [Abstract][Full Text] [Related]
29. Genetic markers associated with progression in early mycosis fungoides.
Johnson VE; Vonderheid EC; Hess AD; Eischen CM; McGirt LY
J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1431-5. PubMed ID: 24171863
[TBL] [Abstract][Full Text] [Related]
30. Altered microRNA expression in folliculotropic and transformed mycosis fungoides.
Marosvári D; Téglási V; Csala I; Marschalkó M; Bödör C; Timár B; Csomor J; Hársing J; Reiniger L
Pathol Oncol Res; 2015 Jul; 21(3):821-5. PubMed ID: 25698383
[TBL] [Abstract][Full Text] [Related]
31. Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea.
Su LD; Kim YH; LeBoit PE; Swetter SM; Kohler S
J Cutan Pathol; 2002 Mar; 29(3):135-41. PubMed ID: 11972709
[TBL] [Abstract][Full Text] [Related]
32. Hypopigmented mycosis fungoides: case reports and literature review.
Qari MS; Li N; Demierre MF
J Cutan Med Surg; 2000 Jul; 4(3):142-8. PubMed ID: 11003719
[TBL] [Abstract][Full Text] [Related]
33. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
Fivenson DP; Hanson CA; Nickoloff BJ
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
[TBL] [Abstract][Full Text] [Related]
34. [Mycosis fungoides in childhood and adolescence with clonal T-cell receptor gamma gene rearrangement. Two cases].
Krokowski M; Winzer M; Lange K; Thorns C; Gafumbegete E; Feller AC; Merz H
Hautarzt; 2003 Jun; 54(6):536-40. PubMed ID: 12759739
[TBL] [Abstract][Full Text] [Related]
35. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
[TBL] [Abstract][Full Text] [Related]
36. Mycosis fungoides progression could be regulated by microRNAs.
Manso R; Martínez-Magunacelaya N; Eraña-Tomás I; Monsalvez V; Rodríguez-Peralto JL; Ortiz-Romero PL; Santonja C; Cristóbal I; Piris MA; Rodríguez-Pinilla SM
PLoS One; 2018; 13(6):e0198477. PubMed ID: 29894486
[TBL] [Abstract][Full Text] [Related]
37. Outcome in 34 patients with juvenile-onset mycosis fungoides: a clinical, immunophenotypic, and molecular study.
Wain EM; Orchard GE; Whittaker SJ; Spittle M Sc MF; Russell-Jones R
Cancer; 2003 Nov; 98(10):2282-90. PubMed ID: 14601100
[TBL] [Abstract][Full Text] [Related]
38. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
39. A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis.
Alberti-Violetti S; Sapienza MR; Del Corvo M; Melle F; Motta G; Venegoni L; Cerroni L; Cota C; Pileri A; Berti E; Pileri SA
Cells; 2023 Jul; 12(15):. PubMed ID: 37566023
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide down-regulates antiapoptotic genes and induces cell death in mycosis fungoides tumors in a mouse model.
Tun-Kyi A; Qin JZ; Oberholzer PA; Navarini AA; Hassel JC; Dummer R; Döbbeling U
Ann Oncol; 2008 Aug; 19(8):1488-1494. PubMed ID: 18349030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
